<DOC>
	<DOCNO>NCT00395369</DOCNO>
	<brief_summary>Cognitive neurological dysfunction coronary artery bypass surgery ( CABG ) common multi-factorial origin . Several previous study show intraoperative aprotinin administration may neuroprotective.in current prospective randomized study , effect intraoperative aprotinin administration integrity optic nerve retinal nerve fiber layer examine . Optical coherance tomography use examin optic nerve retinal nerve fiber layer .</brief_summary>
	<brief_title>Effect Intraoperative Aprotinin Administration Post Cardiac Surgery Optic Nerve Retinal Thickness .</brief_title>
	<detailed_description>Cognitive neurological dysfunction coronary artery bypass surgery ( CABG ) common multi-factorial origin . Causative factor include cerebral Embolization ( 1 ) , cerebral ischemia reperfusion ( 2 ) , cerebral hyperthermia discontinuation cardiopulmonary bypass ( CPB ) ( 3 ) , systemic inflammatory response CPB ( 4 ) . Cognitive dysfunction report 53 % patient discharge hospital , 36 % six week 42 % five year ( 5 ) . Cognitive function discharge hospital predictor long-term cognitive outcome ( 5 ) . Adverse neurological outcome classify : type I ( focal neurological injury , stupor coma ) type II ( deterioration intellectual function , memory deficit seizure ) . Patients adverse cerebral outcome great in-hospital mortality , long hospitalization great rate discharge facility intermediate long-term care ( 6 ) . Adverse neurological outcome otherwise successful surgery devastate patient , family society . Neurocognitive test establish method ass post cardiac surgery cognitive outcome . Despite extensive use neurocognitive testing procedure research literature , uncertainty regard precise interpretation finding give study . Thus , new tool evaluate cognitive outcome investigate . Aprotinin naturally occur serine protease inhibitor use increase frequency cardiac surgery reduce blood loss need perioperative blood transfusion . Through inhibition serine proteases plasmin , aprotinin significantly reduces fibrinolysis , thereby aid hemostasis surgical procedure . These proven benefit supplement anti-inflammatory property aprotinin , may help curb deleterious effect cardiopulmonary bypass . Two aprotinin dose regimen use prophylactic reduction perioperative blood loss need blood transfusion patient undergoing cardiopulmonary bypass ( CPB ) . Serum concentration achieve full-dose regimen inhibit kallikrein plasmin activity result attenuation systemic inflammatory response bypass , whereas serum concentration achieve half-dose regimen inhibit plasmin activity . In-spite fact aprotinin administer decade cardiac surgery patient , 's safety still controversial . Several study report increase risk postoperative MI , CVA renal failure 's usage . Thus , usage standard care , depend surgeon decision ( 13 ) . Evidence support neuroprotective effect aprotinin give surgery obtain several study . In post hoc analysis 816 CABG patient multicenter study ( 7 ) , aprotinin administration associate significantly ( P = 0.04 ) decrease incidence stroke ( 3.1 % vs. 0.0 % ) . A meta-analysis ( 8 ) placebo-controlled , randomize , double-blind study CABG patient receive high-dose aprotinin placebo support hypothesis report stroke incidence 4.2 % vs. 0 % . A number prospective study show reduction post cardiac surgery cognitive deficit aprotinin administer CPB ( 9-10 ) . Although , mechanism aprotinin may confer neuroprotection know , anti-inflammatory effect postulate . Another possible neuroprotective mechanism improve recovery cerebral metabolism ischemia ( 11 ) . Its main site action may microcirculation , decrease ischemic injury decrease bradykinin generation ( 12 ) provide good microcirculatory environment early reperfusion . Processes inflict Cerebrovascular ischemia inflammatory damage may also affect optic nerve . Thus , pathophysiological finding discover optic nerve image reflect cerebrovascular status . Ischemic damage optic nerve ischemic optic neuropathy ( ION ) know complication CABG . ION describe defect optic nerve lead irreversible loss vision case . Influenced variety factor , pathophysiological microvascular change believe provoke anterior ischemic neuropathy sudden painless loss vision . Since therapeutic trial fail , reliable effective treatment anterior ischemic optic neuropathy prevention possible cause way avoid rare severe complication cardiac surgery . The following risk factor determine ION follow CABG : History glaucoma ophthalmological problem , prolong cardiopulmonary bypass-time , myocardial ischemia , general edema cardiopulmonary bypass , excessive hemodilution low hemoglobin hematocrit , hypo- hypertension , systemic hypothermia , need vasoactive medication , diabetes anemia . RNFL thickness measure optical coherence tomography OCT show correlate well optic nerve atrophy visual function optic neuritis14 , 15 . Using OCT measurement optic nerve retinal nerve fiber layer ( RNFL ) thickness visual field test primary outcome , hypothesize high-dose aprotinin administration would decrease incidence severity optic nerve retinal injury follow CABG CPB . Materials Methods : Patients schedule primary CABG study . Exclusion criterion : Preoperative : 1 . Patients require concomitant noncoronary procedure . 2 . Urgent operation . 3 . Intra aortic balloon pump 4 . Presence allergy aprotinin bleed diathesis . 5 . Previous CVA . 6 . Previous eye operation . 7 . Glaucoma . 8 . Retinopathy . Postoperative : 1 . Postoperative CVA . 2 . Postoperative critical condition preclude safe performance OCT examination . Anesthesia , surgery postoperative management Oral lorazepam 0.02 0.03 mg/kg administer patient two hour surgery . General anesthesia induce fentanyl 15 20 µg/kg ketamin . Muscle relaxation achieve use pancuronium 0.1 mg/kg . Before cannulation heart , heparin ( least 300 U/kg iv ) administer patient . Additional heparin administer achieve maintain cephalin kaolin time &gt; 480 sec . CPB institute use hollow fibre oxygenator ( -- ) 40-µm screen arterial filter ( ) crystalloid prim non-pulsatile flow 32.0 34.0°C . Pump prime consist lactated Ringer ’ solution 2000 mL , sodium bicarbonate 8.4 % 50 mL mannitol 20 % 3 mL/kg . The pump flow rate maintain 2.4 L/min x m–2 aortic cross clamping . During CPB , pump flow adjust maintain mean arterial pressure 65 80 mmHg hematocrit maintain 20 25 % . Intermittent use cardiotomy suction ( ) ( 0.5–1 L flow ) pericardiotomy closure pericardium use . A cell saver device use . Myocardial protection intermittent antegrade retrograde blood cardioplegia administer via aortic root coronary sinus respectively . A single aortic cross-clamp use complete distal proximal anastamosis . Aortic venting use patient . At end surgery , patient transfer intensive care unit , mechanical ventilation continue local criterion wean tracheal extubation meet . Administration study drug : Patients randomize treatment group placebo . In treatment group , aprotinin administer , consist 2 x 106 KIU load dose induction anesthesia , 2 x 106 KIU add CPB circuit prime , continuous infusion 5 x 105 KIU•hr–1 surgery . The infusion discontinue end surgery . Patients ophthalmologist unaware study group patient belong . OCT Visual Field measurement : OCT measurement visual field examination perform patient prior , 7 day one month surgery .</detailed_description>
	<mesh_term>Aprotinin</mesh_term>
	<criteria>patient admit coronary artery bypass surgery Preoperative : Patients require concomitant noncoronary procedure . Urgent operation . Intra aortic balloon pump Presence allergy aprotinin bleed diathesis . Previous CVA . Previous eye operation . Glaucoma . Retinopathy . Postoperative : Postoperative CVA . Postoperative critical condition preclude safe performance OCT examination .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>aprotinin</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>neurological dysfunction</keyword>
	<keyword>optical coherance tomography</keyword>
</DOC>